Produkty 103881-93-2

CAS 103881-93-2 występuje w naszej ofercie pod nazwami: 4,5-Dihydro Prednisone, (5a)-17,21-Dihydroxypregn-1-ene-3,11,20-trione. Oferty producentów: TRC, Biosynth. Dostępne opakowania: 10mg, 1mg, 50mg.

4,5-Dihydro Prednisone
TRC
  • opakowanie: 10mg, 1mg
  • Warianty: 2
Zobacz produkt
(5a)-17,21-Dihydroxypregn-1-ene-3,11,20-trione
Biosynth
  • opakowanie: 50mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(5S,8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-4,5,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11-dione (CAS 103881-93-2) to związek chemiczny o wzorze sumarycznym C21H28O5 i masie molowej 360.4 g/mol. Nazwa systematyczna IUPAC: (5S,8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-4,5,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11-dione. InChIKey: XGRPDOONUXQWRT-FZPGBCFJSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H28O5
Masa molowa360.4 g/mol
Nazwa IUPAC(5S,8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-4,5,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11-dione
InChIKeyXGRPDOONUXQWRT-FZPGBCFJSA-N
SMILESC[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CC[C@@H]4[C@@]3(C=CC(=O)C4)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 4,5-Dihydro Prednisone, 4,5-Dihydroprednisone, (5alpha)-, 5alpha-Pregn-1-ene-3,11,20-trione, 17,21-dihydroxy-, Pregn-1-ene-3,11,20-trione, 17,21-dihydroxy-, (5alpha)-, (5a)-17,21-Dihydroxypregn-1-ene-3,11,20-trione, (5alpha)-4,5-dihydroprednisone, 17alpha,21-Dihydroxypregn-1-ene-3,11,20-trione, (5alpha)-17,21-Dihydroxypregn-1-ene-3,11,20-trione, 17,21-Dihydroxy-5alpha-Pregn-1-ene-3,11,20-trione, 17alpha,21-dihydroxy-5alpha-pregn1-ene-3,11,20-trione
Izomery (ten sam wzór sumaryczny)
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C21H28O5
(8S,9S,10R,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-17-hydroxy-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione C21H28O5
(8S,9S,10R,13S,14S,17R)-1,2-dideuterio-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11-dione C21H28O5
2-hydroxy-2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]acetic acid C21H28O5
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11-dione C21H28O5
2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoacetaldehyde C21H28O5
(8R,9S,10R,13S,14S,16R,17S)-16,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C21H28O5
(8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C21H28O5
(1S,2S,10S,11S,14R,15S,17S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyl-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-en-5-one C21H28O5
11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C21H28O5
1,3-bis[4-(2-methoxyethyl)phenoxy]propan-2-ol C21H28O5
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one C21H28O5